UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Association between progestin-only contraceptive use and cardiometabolic outcomes: A systematic review and meta-analysis

Glisic, Marija; Shahzad, Sara; Tsoli, Stergiani; Chadni, Mahmuda; Asllanaj, Eralda; Rojas, Lyda Z; Brown, Elizabeth; ... Franco, Oscar H; + view all (2018) Association between progestin-only contraceptive use and cardiometabolic outcomes: A systematic review and meta-analysis. European Journal of Preventive Cardiology , 25 (10) pp. 1042-1052. 10.1177/2047487318774847. Green open access

[thumbnail of Glisic et all.pdf]
Preview
Text
Glisic et all.pdf - Published Version

Download (506kB) | Preview

Abstract

Aims: The association between progestin-only contraceptive (POC) use and the risk of various cardiometabolic outcomes has rarely been studied. We performed a systematic review and meta-analysis to determine the impact of POC use on cardiometabolic outcomes including venous thromboembolism, myocardial infarction, stroke, hypertension and diabetes./ Methods and results: Nineteen observational studies (seven cohort and 12 case–control) were included in this systematic review. Of those, nine studies reported the risk of venous thromboembolism, six reported the risk of myocardial infarction, six reported the risk of stroke, three reported the risk of hypertension and two studies reported the risk of developing diabetes with POC use. The pooled adjusted relative risks (RRs) for venous thromboembolism, myocardial infarction and stroke for oral POC users versus non-users based on the random effects model were 1.06 (95% confidence interval (CI) 0.70–1.62), 0.98 (95% CI 0.66–1.47) and 1.02 (95% CI 0.72–1.44), respectively. Stratified analysis by route of administration showed that injectable POC with a RR of 2.62 (95% CI 1.74–3.94), but not oral POCs (RR 1.06, 95% CI 0.7–1.62), was associated with an increased risk of venous thromboembolism. A decreased risk of venous thromboembolism in a subgroup of women using an intrauterine levonorgestrel device was observed with a RR of 0.53 (95% CI 0.32–0.89). No effect of POC use on blood pressure was found, but there was an indication for an increased risk of diabetes with injectable POCs, albeit non-significant./ Conclusions: This systematic review and meta-analysis suggests that oral POC use is not associated with an increased risk of developing various cardiometabolic outcomes, whereas injectable POC use might increase the risk of venous thromboembolism.

Type: Article
Title: Association between progestin-only contraceptive use and cardiometabolic outcomes: A systematic review and meta-analysis
Open access status: An open access version is available from UCL Discovery
DOI: 10.1177/2047487318774847
Publisher version: https://doi.org/10.1177/2047487318774847
Language: English
Additional information: © The Author(s). This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Keywords: Progestogen, progesterone, progestin-only pill, contraception, stroke, myocardial infarction, venous thromboembolism, hypertension, type 2 diabetes, women, cardiometabolic risk
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science > Population Science and Experimental Medicine
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science > Population Science and Experimental Medicine > MRC Unit for Lifelong Hlth and Ageing
URI: https://discovery.ucl.ac.uk/id/eprint/10166773
Downloads since deposit
13Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item